City

Barcelona (1)

Richmond (1)

Shanghai (1)

Condition

Covert Hepatic Encephalopathy (3)

Cirrhosis (1)

Hepatic Encephalopathy (1)

Minimal Hepatic Encephalopathy (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Sign in for free

Phase

n/a (1)

phase 2 (1)

phase 4 (1)

Sponsor

Consorci Sanitari de l'Alt Penedes i Garraf (1)

Hunter Holmes Mcguire Veteran Affairs Medical Center (1)

Shanghai Changzheng Hospital (1)

Collaborator

Instituto Grifols, S.A. (1)

McGuire Research Institute (1)

Intervention

25% iv albumin (1)

gelsectan (1)

placebo (1)

rifaximin (1)

Study Documents

Intervention Type

biological (1)

dietary supplement (1)

drug (1)

other (1)

Funder Type

Other (2)

U.S. Fed (1)

Study Type

Interventional (3)

covert hepatic encephalopathy

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cirrhosis, Hepatic Encephalopathy, Minimal Hepatic Encephalopathy Trial in Richmond (25% IV albumin, Placebo)

Completed

Cirrhosis
+3 more

25% IV albumin
Placebo

Richmond, Virginia

Hunter Holmes McGuire VA Medical Center

May 25, 2022

Covert Hepatic Encephalopathy Trial in Barcelona (Gelsectan)

Not yet recruiting

Covert Hepatic Encephalopathy

Gelsectan

Barcelona, Cataluña, Spain

Consorci Sanitari Alt'Pènedes i Garraf

Mar 9, 2022

Covert Hepatic Encephalopathy Trial in Shanghai (Rifaximin)

Completed

Covert Hepatic Encephalopathy

Rifaximin

Shanghai, Shanghai, China

Shanghai changzheng Hospital

Jun 28, 2021